(Q37942489)

25 August 2017

1 reference

title

Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity (English)

1 reference

25 August 2017

Vivek Bhakta Mathema

1

0 references

author name string

Young-Sang Koh

series ordinal

2

1 reference

25 August 2017

publication date

5 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

33

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-7

1 reference

Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Cell Cycle Regulator ING4 Is a Suppressor of Melanoma Angiogenesis That Is Regulated by the Metastasis Suppressor BRMS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Functional impact of cancer-associated mutations in the tumor suppressor protein ING4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Nuclear localization signal of ING4 plays a key role in its binding to p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Molecular Basis of Histone H3K4me3 Recognition by ING4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Reviewing the current classification of inhibitor of growth family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Phylogenetic analysis of the ING family of PHD finger proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Function of the ING family of PHD proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Detection of novel mRNA splice variants of human ING4 tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The dimeric structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Role of Jade-1 in the histone acetyltransferase (HAT) HBO1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING4 Mediates Crosstalk between Histone H3 K4 Trimethylation and H3 Acetylation to Attenuate Cellular Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

HDAC2 regulates chromatin plasticity and enhances DNA vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Basement membranes: structure, assembly and role in tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The sponge/Matrigel angiogenesis assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The role of ING tumor suppressors in UV stress response and melanoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Role of ING4 in human melanoma cell migration, invasion and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Allelic losses in localized prostate cancer: association with prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Direct observation demonstrates that Liprin-alpha is required for trafficking of synaptic vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Down-regulation of ING4 is associated with initiation and progression of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Nuclear factor-kappa B: from clone to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

MicroRNAs in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Pattern recognition receptors and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING3 promotes UV-induced apoptosis via Fas/caspase-8 pathway in melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

The p33ING1b tumor suppressor cooperates with p53 to induce apoptosis in response to etoposide in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

p53 polymorphisms: cancer implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0249-3

ING2 in cell cycle regulation

21 January 2018

1 reference

12 December 2020

Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4.

1 reference

12 December 2020

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity

1 reference

12 December 2020

ING Genes Work as Tumor Suppressor Genes in the Carcinogenesis of Head and Neck Squamous Cell Carcinoma

1 reference

12 December 2020

The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions

1 reference

12 December 2020

10.1007/S13277-011-0249-3

Identifiers

DOI

1 reference

25 August 2017

1 reference